153 related articles for article (PubMed ID: 38576594)
21. Iron Administration Overcomes Resistance to Erastin-Mediated Ferroptosis in Ovarian Cancer Cells.
Battaglia AM; Sacco A; Perrotta ID; Faniello MC; Scalise M; Torella D; Levi S; Costanzo F; Biamonte F
Front Oncol; 2022; 12():868351. PubMed ID: 35433479
[TBL] [Abstract][Full Text] [Related]
22. Iron metabolism in colorectal cancer: a balancing act.
Estêvão D; da Cruz-Ribeiro M; Cardoso AP; Costa ÂM; Oliveira MJ; Duarte TL; da Cruz TB
Cell Oncol (Dordr); 2023 Dec; 46(6):1545-1558. PubMed ID: 37273145
[TBL] [Abstract][Full Text] [Related]
23. WIPI2 enhances the vulnerability of colorectal cancer cells to erastin via bioinformatics analysis and experimental verification.
Yu L; Luo Y; Ding X; Tang M; Gao H; Zhang R; Chen M; Liu Y; Chen Q; Ouyang Y; Wang X; Zhen H
Front Oncol; 2023; 13():1146617. PubMed ID: 37207153
[TBL] [Abstract][Full Text] [Related]
24. Musashi-2 Deficiency Triggers Colorectal Cancer Ferroptosis by Downregulating the MAPK Signaling Cascade to Inhibit HSPB1 Phosphorylation.
Meng X; Peng X; Ouyang W; Li H; Na R; Zhou W; You X; Li Y; Pu X; Zhang K; Xia J; Wang J; Zhuang G; Tang H; Peng Z
Biol Proced Online; 2023 Dec; 25(1):32. PubMed ID: 38041016
[TBL] [Abstract][Full Text] [Related]
25. B7H3 increases ferroptosis resistance by inhibiting cholesterol metabolism in colorectal cancer.
Jin H; Zhu M; Zhang D; Liu X; Guo Y; Xia L; Chen Y; Chen Y; Xu R; Liu C; Xi Q; Xia S; Shi T; Zhang G
Cancer Sci; 2023 Nov; 114(11):4225-4236. PubMed ID: 37661645
[TBL] [Abstract][Full Text] [Related]
26. MiR-148a-3p Promotes Colorectal Cancer Cell Ferroptosis by Targeting SLC7A11.
Martino E; Balestrieri A; Aragona F; Bifulco G; Mele L; Campanile G; Balestrieri ML; D'Onofrio N
Cancers (Basel); 2023 Aug; 15(17):. PubMed ID: 37686618
[TBL] [Abstract][Full Text] [Related]
27. AKR1C4 regulates the sensitivity of colorectal cancer cells to chemotherapy through ferroptosis modulation.
Wang L; Lv C; Liu X
Cancer Chemother Pharmacol; 2024 Jun; ():. PubMed ID: 38890190
[TBL] [Abstract][Full Text] [Related]
28. Review of ferroptosis in colorectal cancer: Friends or foes?
Wu Z; Fang ZX; Hou YY; Wu BX; Deng Y; Wu HT; Liu J
World J Gastroenterol; 2023 Jan; 29(3):469-486. PubMed ID: 36688016
[TBL] [Abstract][Full Text] [Related]
29. TIMP1 represses sorafenib-triggered ferroptosis in colorectal cancer cells by activating the PI3K/Akt signaling pathway.
Wang L; Wang J; Chen L
Immunopharmacol Immunotoxicol; 2023 Dec; 45(4):419-425. PubMed ID: 36541209
[TBL] [Abstract][Full Text] [Related]
30. Ferroptosis open a new door for colorectal cancer treatment.
Liang H; He X; Tong Y; Bai N; Pu Y; Han K; Wang Y
Front Oncol; 2023; 13():1059520. PubMed ID: 37007121
[TBL] [Abstract][Full Text] [Related]
31. Application of nanotechnology in reversing therapeutic resistance and controlling metastasis of colorectal cancer.
Ren SN; Zhang ZY; Guo RJ; Wang DR; Chen FF; Chen XB; Fang XD
World J Gastroenterol; 2023 Apr; 29(13):1911-1941. PubMed ID: 37155531
[TBL] [Abstract][Full Text] [Related]
32. Targeting critical pathways in ferroptosis and enhancing antitumor therapy of Platinum drugs for colorectal cancer.
Wang G; Wang JJ; Zhi-Min Z; Xu XN; Shi F; Fu XL
Sci Prog; 2023; 106(1):368504221147173. PubMed ID: 36718538
[TBL] [Abstract][Full Text] [Related]
33. Targeting SLC7A11 specifically suppresses the progression of colorectal cancer stem cells via inducing ferroptosis.
Xu X; Zhang X; Wei C; Zheng D; Lu X; Yang Y; Luo A; Zhang K; Duan X; Wang Y
Eur J Pharm Sci; 2020 Sep; 152():105450. PubMed ID: 32621966
[TBL] [Abstract][Full Text] [Related]
34. Autophagy/ferroptosis in colorectal cancer: Carcinogenic view and nanoparticle-mediated cell death regulation.
Zhang Z; Zhao Y; Wang Y; Zhao Y; Guo J
Environ Res; 2023 Dec; 238(Pt 2):117006. PubMed ID: 37669735
[TBL] [Abstract][Full Text] [Related]
35. Ferroptosis in colorectal cancer: a future target?
Yan H; Talty R; Aladelokun O; Bosenberg M; Johnson CH
Br J Cancer; 2023 Apr; 128(8):1439-1451. PubMed ID: 36703079
[TBL] [Abstract][Full Text] [Related]
36. Cullin-9/p53 mediates HNRNPC degradation to inhibit erastin-induced ferroptosis and is blocked by MDM2 inhibition in colorectal cancer.
Yang L; WenTao T; ZhiYuan Z; Qi L; YuXiang L; Peng Z; Ke L; XiaoNa J; YuZhi P; MeiLing J; QingYang F; GuoDong H; YueXiang W; JianMin X
Oncogene; 2022 Jun; 41(23):3210-3221. PubMed ID: 35505093
[TBL] [Abstract][Full Text] [Related]
37. SNORA56-mediated pseudouridylation of 28 S rRNA inhibits ferroptosis and promotes colorectal cancer proliferation by enhancing GCLC translation.
Xu C; Bian Z; Wang X; Niu N; Liu L; Xiao Y; Zhu J; Huang N; Zhang Y; Chen Y; Wu Q; Sun F; Zhu X; Pan Q
J Exp Clin Cancer Res; 2023 Dec; 42(1):331. PubMed ID: 38049865
[TBL] [Abstract][Full Text] [Related]
38. Novel approaches targeting ferroptosis in treatment of glioma.
Zhao J; Zang F; Huo X; Zheng S
Front Neurol; 2023; 14():1292160. PubMed ID: 38020609
[TBL] [Abstract][Full Text] [Related]
39. Targeted exosome-encapsulated erastin induced ferroptosis in triple negative breast cancer cells.
Yu M; Gai C; Li Z; Ding D; Zheng J; Zhang W; Lv S; Li W
Cancer Sci; 2019 Oct; 110(10):3173-3182. PubMed ID: 31464035
[TBL] [Abstract][Full Text] [Related]
40. Sodium Butyrate Induces CRC Cell Ferroptosis via the CD44/SLC7A11 Pathway and Exhibits a Synergistic Therapeutic Effect with Erastin.
Bian Z; Sun X; Liu L; Qin Y; Zhang Q; Liu H; Mao L; Sun S
Cancers (Basel); 2023 Jan; 15(2):. PubMed ID: 36672372
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
